Categories: Tech

Virtru and Microsoft Reach Settlement in Patent Infringement Case

 | Source: Virtru

WASHINGTON, Aug. 25, 2025 (GLOBE NEWSWIRE) — Virtru Corporation, a leading provider of data protection and privacy software, today announced that it has reached a settlement with Microsoft Corporation in its patent infringement lawsuit.

Virtru’s lawsuit, filed in 2022, alleged that Microsoft’s Purview Message Encryption feature (formerly known as Office 365 Message Encryption) infringed upon three Virtru patents related to sharing encrypted data: U.S. Patent Nos. 8,589,673; 8,874,902; and 9,578,021.

The patented technology leverages a user’s existing identity provider to allow recipients to access encrypted data without requiring new credentials.

The agreement materialized after U.S. District Judge Jamal N. Whitehead denied Microsoft’s motion for summary judgment on June 6, 2025.

The terms of the settlement remain confidential.

About Virtru

Virtru empowers organizations to unlock the power of data while maintaining control wherever it’s stored and shared. From global enterprises to national defense and intelligence agencies, Virtru provides simple, powerful solutions for data-centric security, underpinned by the Trusted Data Format (TDF). Learn more at virtru.com.

Media Contact:

Nick Michael
nick.michael@virtru.com

GlobeNews Wire

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

7 days ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

2 weeks ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

3 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

3 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago